Parabilis Medicines, Inc. (PBLS) financial statements and ratios from SEC XBRL. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Debt / Equity | 0.01 |
| Current Ratio | 17.91 |
| Net Debt / EBITDA | 6.6 |
| Price / Book | 4.29 |
| FCF Yield | -2.8% |
| Industry P/E (Pharmaceutical Products) | 15.1 |
| Sector P/E (Healthcare) | 19.4 |
PBLS overview · PBLS earnings · PBLS KPIs · PBLS documents · PBLS ownership · PBLS peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.